{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,6,8]],"date-time":"2026-06-08T06:58:02Z","timestamp":1780901882992,"version":"3.54.1"},"reference-count":57,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2026,5,29]],"date-time":"2026-05-29T00:00:00Z","timestamp":1780012800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"},{"start":{"date-parts":[[2026,6,8]],"date-time":"2026-06-08T00:00:00Z","timestamp":1780876800000},"content-version":"vor","delay-in-days":10,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"}],"funder":[{"name":"Hubei Provincial Department of Education Science and Technology Research Project","award":["B2024100"],"award-info":[{"award-number":["B2024100"]}]},{"name":"Advantages Discipline Group (Medicine) Project in Higher Education of Hubei Province","award":["2025XKQY31"],"award-info":[{"award-number":["2025XKQY31"]}]},{"name":"Hubei Provincial Natural Science Foundation of China","award":["2024AFD284"],"award-info":[{"award-number":["2024AFD284"]}]},{"name":"Hubei Provincial Clinical Research Center for precision Diagnosis and Treatment of Liver Cancer Open Fund","award":["2025LCOF02"],"award-info":[{"award-number":["2025LCOF02"]}]},{"name":"Shiyan Taihe Hospital hospital-level project","award":["2024JJXM087"],"award-info":[{"award-number":["2024JJXM087"]}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["npj Precis. Onc."],"DOI":"10.1038\/s41698-026-01529-4","type":"journal-article","created":{"date-parts":[[2026,5,29]],"date-time":"2026-05-29T06:03:47Z","timestamp":1780034627000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":0,"title":["SQLE as a potential diagnostic and prognostic biomarker for LIHC: a multi-cohort and spatial study"],"prefix":"10.1038","volume":"10","author":[{"given":"Jin","family":"Xie","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Gao-Chun","family":"Xiao","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xin-Yang","family":"Qu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Rui-Min","family":"Wu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yu-Long","family":"Zou","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hao-Shen","family":"Yu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xue","family":"Hu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-3663-1096","authenticated-orcid":false,"given":"Xu-Sheng","family":"Liu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2026,5,29]]},"reference":[{"key":"1529_CR1","doi-asserted-by":"publisher","unstructured":"Zeng, H. et al. Cancer survival statistics in China 2019\u20132021: a multicenter, population-based study. J. Natl. Cancer Center S2667005424000498 https:\/\/doi.org\/10.1016\/j.jncc.2024.06.005 (2024).","DOI":"10.1016\/j.jncc.2024.06.005"},{"key":"1529_CR2","first-page":"12","volume":"74","author":"RL Siegel","year":"2024","unstructured":"Siegel, R. L., Giaquinto, A. N. & Jemal, A. Cancer statistics, 2024. Ca. Cancer J. Clin. 74, 12\u201349 (2024).","journal-title":"Ca. Cancer J. Clin."},{"key":"1529_CR3","doi-asserted-by":"publisher","first-page":"107327482094597","DOI":"10.1177\/1073274820945975","volume":"27","author":"Y-S Ma","year":"2020","unstructured":"Ma, Y.-S., Liu, J.-B., Wu, T.-M. & Fu, D. New therapeutic options for advanced hepatocellular carcinoma. Cancer Control 27, 1073274820945975 (2020).","journal-title":"Cancer Control"},{"key":"1529_CR4","doi-asserted-by":"publisher","first-page":"1450","DOI":"10.1056\/NEJMra1713263","volume":"380","author":"A Villanueva","year":"2019","unstructured":"Villanueva, A. Hepatocellular carcinoma. N. Engl. J. Med 380, 1450\u20131462 (2019).","journal-title":"N. Engl. J. Med"},{"key":"1529_CR5","doi-asserted-by":"publisher","first-page":"36","DOI":"10.1002\/cai2.60","volume":"2","author":"L Zhang","year":"2023","unstructured":"Zhang, L. et al. Advances in medical treatment of advanced hepatobiliary and pancreatic cancer in 2022. Cancer Innov. 2, 36\u201351 (2023).","journal-title":"Cancer Innov."},{"key":"1529_CR6","doi-asserted-by":"publisher","first-page":"97","DOI":"10.1002\/med4.23","volume":"1","author":"Y Xu","year":"2023","unstructured":"Xu, Y. et al. Complex interplay between the immune system, metabolism, and epigenetic factors in autoimmune liver diseases. Med. Adv. 1, 97\u2013114 (2023).","journal-title":"Med. Adv."},{"key":"1529_CR7","doi-asserted-by":"publisher","first-page":"3547","DOI":"10.3748\/wjg.v22.i13.3547","volume":"22","author":"J-H Sun","year":"2016","unstructured":"Sun, J.-H., Luo, Q., Liu, L.-L. & Song, G.-B. Liver cancer stem cell markers: Progression and therapeutic implications. WJG 22, 3547 (2016).","journal-title":"WJG"},{"key":"1529_CR8","doi-asserted-by":"publisher","first-page":"191","DOI":"10.1016\/j.canlet.2015.07.018","volume":"379","author":"L Li","year":"2016","unstructured":"Li, L. & Wang, H. Heterogeneity of liver cancer and personalized therapy. Cancer Lett. 379, 191\u2013197 (2016).","journal-title":"Cancer Lett."},{"key":"1529_CR9","doi-asserted-by":"publisher","first-page":"1055","DOI":"10.32604\/biocell.2024.050515","volume":"48","author":"Y-N LI","year":"2024","unstructured":"LI, Y.-N. et al. Sciadopitysin exerts anticancer effects on HepG2 hepatocellular carcinoma cells by regulating reactive oxygen species-mediated signaling pathways. BIOCELL 48, 1055\u20131069 (2024).","journal-title":"BIOCELL"},{"key":"1529_CR10","doi-asserted-by":"publisher","first-page":"79","DOI":"10.1515\/oncologie-2023-0472","volume":"26","author":"Y-C Chen","year":"2024","unstructured":"Chen, Y.-C. et al. Catalase expression is an independent prognostic marker in liver hepatocellular carcinoma. Oncologie 26, 79\u201390 (2024).","journal-title":"Oncologie"},{"key":"1529_CR11","doi-asserted-by":"publisher","first-page":"e25022","DOI":"10.53388\/2025825022","volume":"8","author":"X-W Li","year":"2025","unstructured":"Li, X.-W. et al. Identification of MICB as a diagnostic and prognostic biomarker in cancers, and it promotes the drug resistance of hepatocellular carcinoma. Cancer Adv. 8, e25022 (2025).","journal-title":"Cancer Adv."},{"key":"1529_CR12","doi-asserted-by":"publisher","DOI":"10.53388\/2022522022","volume":"5","author":"X Wang","year":"2022","unstructured":"Wang, X. & Chen, Y. The expression significance of RACGAP1 gene in hepatocellular carcinoma and its prognostic effect were analyzed based on TCGA database. Cancer Adv. 5, e22022 (2022).","journal-title":"Cancer Adv."},{"key":"1529_CR13","doi-asserted-by":"publisher","DOI":"10.7717\/peerj.18522","volume":"12","author":"M Chen","year":"2024","unstructured":"Chen, M., Yang, Y., Chen, S., He, Z. & Du, L. Targeting squalene epoxidase in the treatment of metabolic-related diseases: current research and future directions. PeerJ 12, e18522 (2024).","journal-title":"PeerJ"},{"key":"1529_CR14","doi-asserted-by":"publisher","first-page":"188394","DOI":"10.1016\/j.bbcan.2020.188394","volume":"1874","author":"H Xu","year":"2020","unstructured":"Xu, H., Zhou, S., Tang, Q., Xia, H. & Bi, F. Cholesterol metabolism: New functions and therapeutic approaches in cancer. Biochim. Biophys. Acta (BBA) Rev. Cancer 1874, 188394 (2020).","journal-title":"Biochim. Biophys. Acta (BBA) Rev. Cancer"},{"key":"1529_CR15","doi-asserted-by":"publisher","DOI":"10.1016\/j.redox.2024.103407","volume":"77","author":"J Zhang","year":"2024","unstructured":"Zhang, J. et al. Inhibition of KDM4A restricts SQLE transcription and induces oxidative stress imbalance to suppress bladder cancer. Redox Biol. 77, 103407 (2024).","journal-title":"Redox Biol."},{"key":"1529_CR16","doi-asserted-by":"publisher","DOI":"10.1186\/s12885-024-12897-0","volume":"24","author":"Y-C Zhao","year":"2025","unstructured":"Zhao, Y.-C. et al. SQLE\u2014a promising prognostic biomarker in cervical cancer: implications for tumor malignant behavior, cholesterol synthesis, epithelial-mesenchymal transition, and immune infiltration. BMC Cancer 24, 1133 (2025).","journal-title":"BMC Cancer"},{"key":"1529_CR17","doi-asserted-by":"publisher","unstructured":"Liu, X. et al. SQLE amplification accelerates esophageal squamous cell carcinoma tumorigenesis and metastasis through oncometabolite 2,3-oxidosqualene repressing Hippo pathway. CURR. MED. SCI. 217528 https:\/\/doi.org\/10.1016\/j.canlet.2025.217528 (2025).","DOI":"10.1016\/j.canlet.2025.217528"},{"key":"1529_CR18","doi-asserted-by":"publisher","DOI":"10.1016\/j.isci.2025.112853","volume":"28","author":"F He","year":"2025","unstructured":"He, F. et al. Ginsenoside 20(S)-Rg3 upregulates SQLE to reprogram cholesterol metabolism of ovarian cancer cells. iScience 28, 112853 (2025).","journal-title":"iScience"},{"key":"1529_CR19","doi-asserted-by":"publisher","first-page":"1512981","DOI":"10.3389\/fimmu.2024.1512981","volume":"15","author":"J Pan","year":"2025","unstructured":"Pan, J. et al. SQLE-mediated squalene metabolism promotes tumor immune evasion in pancreatic cancer. Front. Immunol. 15, 1512981 (2025).","journal-title":"Front. Immunol."},{"key":"1529_CR20","doi-asserted-by":"publisher","DOI":"10.1038\/s41419-024-07318-w","volume":"16","author":"S Liu","year":"2025","unstructured":"Liu, S. et al. Helicobacter pylori CagA promotes gastric cancer immune escape by upregulating SQLE. Cell Death Dis. 16, 17 (2025).","journal-title":"Cell Death Dis."},{"key":"1529_CR21","doi-asserted-by":"publisher","first-page":"107327482091466","DOI":"10.1177\/1073274820914663","volume":"27","author":"T Shen","year":"2020","unstructured":"Shen, T., Lu, Y. & Zhang, Q. High squalene epoxidase in tumors predicts worse survival in patients with hepatocellular carcinoma: integrated bioinformatic analysis on NAFLD and HCC. Cancer Control 27, 1073274820914663 (2020).","journal-title":"Cancer Control"},{"key":"1529_CR22","doi-asserted-by":"publisher","first-page":"12945","DOI":"10.3748\/wjg.v20.i36.12945","volume":"20","author":"P Dongiovanni","year":"2014","unstructured":"Dongiovanni, P., Romeo, S. & Valenti, L. Hepatocellular carcinoma in nonalcoholic fatty liver: role of environmental and genetic factors. World J. Gastroenterol. 20, 12945\u201312955 (2014).","journal-title":"World J. Gastroenterol."},{"key":"1529_CR23","doi-asserted-by":"publisher","first-page":"2192","DOI":"10.7150\/jca.39579","volume":"11","author":"X Liu","year":"2020","unstructured":"Liu, X. et al. Visualization of gene therapy with a liver cancer-targeted adeno-associated virus 3 vector. J. Cancer 11, 2192\u20132200 (2020).","journal-title":"J. Cancer"},{"key":"1529_CR24","doi-asserted-by":"publisher","DOI":"10.3389\/fonc.2022.809847","volume":"12","author":"X-Y Kui","year":"2022","unstructured":"Kui, X.-Y. et al. Comprehensive analysis of SLC17A9 and its prognostic value in hepatocellular carcinoma. Front Oncol. 12, 809847 (2022).","journal-title":"Front Oncol."},{"key":"1529_CR25","doi-asserted-by":"publisher","first-page":"639","DOI":"10.32604\/biocell.2024.047562","volume":"48","author":"J TANG","year":"2024","unstructured":"TANG, J. et al. Identification prognostic features related to sphingolipid metabolism and experimental validation of TRIM47 in hepatocellular carcinoma. BIOCELL 48, 639\u2013651 (2024).","journal-title":"BIOCELL"},{"key":"1529_CR26","doi-asserted-by":"publisher","first-page":"691","DOI":"10.1515\/oncologie-2023-0289","volume":"25","author":"J Wang","year":"2023","unstructured":"Wang, J., Zhang, Y., Sun, L. & Liu, Y. IMMT promotes hepatocellular carcinoma formation via PI3K\/AKT\/mTOR pathway. Oncologie 25, 691\u2013703 (2023).","journal-title":"Oncologie"},{"key":"1529_CR27","doi-asserted-by":"publisher","first-page":"199","DOI":"10.26599\/NBE.2023.9290024","volume":"15","author":"Y Wu","year":"2023","unstructured":"Wu, Y., Zhang, J., He, W., Li, C. & Wang, Y. Nanomaterials for targeting liver disease: research progress and future perspectives. Nano Biomed. Eng. 15, 199\u2013224 (2023).","journal-title":"Nano Biomed. Eng."},{"key":"1529_CR28","doi-asserted-by":"publisher","first-page":"80","DOI":"10.34133\/bmef.0080","volume":"5","author":"P Datta","year":"2024","unstructured":"Datta, P. et al. Recent advances and future directions in sonodynamic therapy for cancer treatment. BME Front 5, 80 (2024).","journal-title":"BME Front"},{"key":"1529_CR29","doi-asserted-by":"publisher","first-page":"84","DOI":"10.34133\/bmef.0084","volume":"6","author":"C Huan","year":"2025","unstructured":"Huan, C. et al. Spatially resolved multiomics: data analysis from monoomics to multiomics. BME Front 6, 84 (2025).","journal-title":"BME Front"},{"key":"1529_CR30","doi-asserted-by":"publisher","first-page":"3874","DOI":"10.3390\/ijms25073874","volume":"25","author":"L Zhang","year":"2024","unstructured":"Zhang, L. et al. Squalene epoxidase: its regulations and links with cancers. IJMS 25, 3874 (2024).","journal-title":"IJMS"},{"key":"1529_CR31","doi-asserted-by":"publisher","first-page":"938502","DOI":"10.3389\/fonc.2022.938502","volume":"12","author":"Y Zou","year":"2022","unstructured":"Zou, Y., Zhang, H., Bi, F., Tang, Q. & Xu, H. Targeting the key cholesterol biosynthesis enzyme squalene monooxygenasefor cancer therapy. Front. Oncol. 12, 938502 (2022).","journal-title":"Front. Oncol."},{"key":"1529_CR32","doi-asserted-by":"publisher","DOI":"10.1002\/advs.202411719","volume":"12","author":"D Cai","year":"2025","unstructured":"Cai, D. et al. Targeting FDFT1 reduces cholesterol and bile acid production and delays hepatocellular carcinoma progression through the HNF4A\/ALDOB\/AKT1 axis. Adv. Sci. 12, e2411719 (2025).","journal-title":"Adv. Sci."},{"key":"1529_CR33","doi-asserted-by":"publisher","first-page":"322","DOI":"10.1038\/s41420-025-02621-7","volume":"11","author":"F Chen","year":"2025","unstructured":"Chen, F. et al. CYP51A1 in health and disease: from sterol metabolism to regulated cell death. Cell Death Discov. 11, 322 (2025).","journal-title":"Cell Death Discov."},{"key":"1529_CR34","doi-asserted-by":"publisher","first-page":"3102","DOI":"10.1158\/0008-5472.CAN-21-2934","volume":"82","author":"EHK Mok","year":"2022","unstructured":"Mok, E. H. K. et al. Caspase-3\u2013induced activation of SREBP2 drives drug resistance via promotion of cholesterol biosynthesis in hepatocellular carcinoma. Cancer Res 82, 3102\u20133115 (2022).","journal-title":"Cancer Res"},{"key":"1529_CR35","doi-asserted-by":"publisher","first-page":"1538658","DOI":"10.3389\/fimmu.2025.1538658","volume":"16","author":"F Liu","year":"2025","unstructured":"Liu, F. et al. m6A epitranscriptomic modification in hepatocellular carcinoma: implications for the tumor microenvironment and immunotherapy. Front. Immunol. 16, 1538658 (2025).","journal-title":"Front. Immunol."},{"key":"1529_CR36","doi-asserted-by":"publisher","first-page":"912","DOI":"10.3390\/biom15070912","volume":"15","author":"J Lu","year":"2025","unstructured":"Lu, J. et al. The multifaceted role of VIRMA, a core component of the methyltransferase complex, in cancer and cancer therapy. Biomolecules 15, 912 (2025).","journal-title":"Biomolecules"},{"key":"1529_CR37","doi-asserted-by":"publisher","first-page":"188493","DOI":"10.1016\/j.bbcan.2020.188493","volume":"1875","author":"R Gillman","year":"2021","unstructured":"Gillman, R., Lopes Floro, K., Wankell, M. & Hebbard, L. The role of DNA damage and repair in liver cancer. Biochim. Biophys. Acta (BBA) - Rev. Cancer 1875, 188493 (2021).","journal-title":"Biochim. Biophys. Acta (BBA) - Rev. Cancer"},{"key":"1529_CR38","doi-asserted-by":"publisher","DOI":"10.1186\/s12943-019-1106-z","volume":"18","author":"T Lan","year":"2019","unstructured":"Lan, T. et al. KIAA1429 contributes to liver cancer progression through N6-methyladenosine-dependent post-transcriptional modification of GATA3. Mol. Cancer 18, 186 (2019).","journal-title":"Mol. Cancer"},{"key":"1529_CR39","doi-asserted-by":"publisher","DOI":"10.1038\/s41467-021-26460-z","volume":"12","author":"Z Zheng","year":"2021","unstructured":"Zheng, Z. et al. Lung mesenchymal stromal cells influenced by Th2 cytokines mobilize neutrophils and facilitate metastasis by producing complement C3. Nat. Commun. 12, 6202 (2021).","journal-title":"Nat. Commun."},{"key":"1529_CR40","doi-asserted-by":"publisher","DOI":"10.1186\/s12935-024-03515-x","volume":"24","author":"Z Li","year":"2024","unstructured":"Li, Z., Wu, Z., You, X. & Tang, N. Pan-cancer analysis reveals that TK1 promotes tumor progression by mediating cell proliferation and Th2 cell polarization. Cancer Cell Int. 24, 329 (2024).","journal-title":"Cancer Cell Int."},{"key":"1529_CR41","doi-asserted-by":"publisher","DOI":"10.1186\/s12885-024-12025-y","volume":"24","author":"Y Ouyang","year":"2024","unstructured":"Ouyang, Y. et al. AMPK\u03b12 promotes tumor immune escape by inducing CD8+ T-cell exhaustion and CD4+ Treg cell formation in liver hepatocellular carcinoma. BMC Cancer 24, 276 (2024).","journal-title":"BMC Cancer"},{"key":"1529_CR42","doi-asserted-by":"publisher","first-page":"1731","DOI":"10.1158\/1535-7163.MCT-24-0222","volume":"23","author":"X Yang","year":"2024","unstructured":"Yang, X. et al. Targeting PDHK1 by DCA to restore NK cell function in hepatocellular carcinoma. Mol. Cancer Ther. 23, 1731\u20131742 (2024).","journal-title":"Mol. Cancer Ther."},{"key":"1529_CR43","doi-asserted-by":"publisher","first-page":"306","DOI":"10.1002\/med4.37","volume":"1","author":"H Zhang","year":"2023","unstructured":"Zhang, H. et al. Oncogenic viral antigens for engineered T cell immunotherapy: Challenges and opportunities. Med. Adv. 1, 306\u2013317 (2023).","journal-title":"Med. Adv."},{"key":"1529_CR44","doi-asserted-by":"publisher","first-page":"D991","DOI":"10.1093\/nar\/gks1193","volume":"41","author":"T Barrett","year":"2012","unstructured":"Barrett, T. et al. NCBI GEO: archive for functional genomics data sets\u2014update. Nucleic Acids Res. 41, D991\u2013D995 (2012).","journal-title":"Nucleic Acids Res."},{"key":"1529_CR45","doi-asserted-by":"crossref","unstructured":"Tomczak, K., Czerwi\u0144ska, P. & Wiznerowicz, M. Review The Cancer Genome Atlas (TCGA): an immeasurable source of knowledge. OWsp\u00f3\u0142czesna Onkol 1A, 68\u201377 (2015).","DOI":"10.5114\/wo.2014.47136"},{"key":"1529_CR46","doi-asserted-by":"publisher","DOI":"10.1093\/nar\/gkv007","volume":"43","author":"ME Ritchie","year":"2015","unstructured":"Ritchie, M. E. et al. limma powers differential expression analyses for RNA-sequencing and microarray studies. Nucleic Acids Res. 43, e47 (2015).","journal-title":"Nucleic Acids Res."},{"key":"1529_CR47","doi-asserted-by":"publisher","DOI":"10.1186\/s13059-014-0550-8","volume":"15","author":"MI Love","year":"2014","unstructured":"Love, M. I., Huber, W. & Anders, S. Moderated estimation of fold change and dispersion for RNA-seq data with DESeq2. Genome Biol. 15, 550 (2014).","journal-title":"Genome Biol."},{"key":"1529_CR48","doi-asserted-by":"publisher","first-page":"D607","DOI":"10.1093\/nar\/gky1131","volume":"47","author":"D Szklarczyk","year":"2019","unstructured":"Szklarczyk, D. et al. STRING v11: protein-protein association networks with increased coverage,supporting functional discovery in genome-wide experimental datasets. Nucleic Acids Res. 47, D607\u2013D613 (2019).","journal-title":"Nucleic Acids Res."},{"key":"1529_CR49","doi-asserted-by":"publisher","first-page":"W214","DOI":"10.1093\/nar\/gkq537","volume":"38","author":"D Warde-Farley","year":"2010","unstructured":"Warde-Farley, D. et al. The GeneMANIA prediction server: biological network integration for geneprioritization and predicting gene function. Nucleic Acids Res. 38, W214\u201320 (2010).","journal-title":"Nucleic Acids Res."},{"key":"1529_CR50","doi-asserted-by":"publisher","first-page":"284","DOI":"10.1089\/omi.2011.0118","volume":"16","author":"G Yu","year":"2012","unstructured":"Yu, G., Wang, L.-G., Han, Y. & He, Q.-Y. clusterProfiler: an R package for comparing biological themes among gene clusters. OMICS J. Integr. Biol. 16, 284\u2013287 (2012).","journal-title":"OMICS J. Integr. Biol."},{"key":"1529_CR51","doi-asserted-by":"publisher","first-page":"W98","DOI":"10.1093\/nar\/gkx247","volume":"45","author":"Z Tang","year":"2017","unstructured":"Tang, Z. et al. GEPIA: a web server for cancer and normal gene expression profiling and interactive analyses. Nucleic Acids Res. 45, W98\u2013W102 (2017).","journal-title":"Nucleic Acids Res."},{"key":"1529_CR52","doi-asserted-by":"publisher","DOI":"10.1186\/s40001-025-02541-3","volume":"30","author":"X-S Liu","year":"2025","unstructured":"Liu, X.-S. et al. The potential of MCM8 as a biomarker in esophageal carcinoma: a comprehensive analysis integrating m6a methylation and angiogenesis. Eur. J. Med Res. 30, 373 (2025).","journal-title":"Eur. J. Med Res."},{"key":"1529_CR53","first-page":"818","volume":"13","author":"X-S Liu","year":"2023","unstructured":"Liu, X.-S. et al. DARS2 is a prognostic biomarker and correlated with immune infiltrates and cuproptosis in lung adenocarcinoma. Am. J. Cancer Res. 13, 818\u2013834 (2023).","journal-title":"Am. J. Cancer Res."},{"key":"1529_CR54","doi-asserted-by":"publisher","DOI":"10.3389\/fphar.2022.1010879","volume":"13","author":"X-S Liu","year":"2022","unstructured":"Liu, X.-S. et al. Nucleophosmin 1 is a prognostic marker of gastrointestinal cancer and is associated with m6A and cuproptosis. Front Pharm. 13, 1010879 (2022).","journal-title":"Front Pharm."},{"key":"1529_CR55","doi-asserted-by":"publisher","first-page":"715883","DOI":"10.3389\/fcell.2021.715883","volume":"9","author":"X-S Liu","year":"2021","unstructured":"Liu, X.-S. et al. Comprehensive analysis of hexokinase 2 immune infiltrates and m6A related genes in human esophageal carcinoma. Front. Cell Dev. Biol. 9, 715883 (2021).","journal-title":"Front. Cell Dev. Biol."},{"key":"1529_CR56","doi-asserted-by":"publisher","first-page":"7","DOI":"10.1186\/1471-2105-14-7","volume":"14","author":"S H\u00e4nzelmann","year":"2013","unstructured":"H\u00e4nzelmann, S., Castelo, R. & Guinney, J. GSVA: gene set variation analysis for microarray and RNA-Seq data. BMC Bioinform. 14, 7 (2013).","journal-title":"BMC Bioinform."},{"key":"1529_CR57","doi-asserted-by":"publisher","first-page":"782","DOI":"10.1016\/j.immuni.2013.10.003","volume":"39","author":"G Bindea","year":"2013","unstructured":"Bindea, G. et al. Spatiotemporal dynamics of intratumoral immune cells reveal the immune landscape in human cancer. Immunity 39, 782\u2013795 (2013).","journal-title":"Immunity"}],"container-title":["npj Precision Oncology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.nature.com\/articles\/s41698-026-01529-4","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41698-026-01529-4.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41698-026-01529-4.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,6,8]],"date-time":"2026-06-08T06:03:31Z","timestamp":1780898611000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.nature.com\/articles\/s41698-026-01529-4"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,5,29]]},"references-count":57,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2026,12]]}},"alternative-id":["1529"],"URL":"https:\/\/doi.org\/10.1038\/s41698-026-01529-4","relation":{},"ISSN":["2397-768X"],"issn-type":[{"value":"2397-768X","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,5,29]]},"assertion":[{"value":"29 January 2026","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"22 May 2026","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"29 May 2026","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"The authors declare no competing interests.","order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}],"article-number":"207"}}